South Carolina Multistate Pharmacy Jurisprudence Examination (MPJE) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Prepare for the South Carolina MPJE with flashcards and multiple choice questions. Each question offers hints and explanations to enhance your understanding. Get exam-ready today!

Practice this question and more.


What measure is a key component of the Orphan Drug Act?

  1. Fast tracking for all new drugs

  2. Tax incentives for orphan drug development

  3. Mandatory disclosure of drug side effects

  4. Universal healthcare coverage

The correct answer is: Tax incentives for orphan drug development

The key component of the Orphan Drug Act is tax incentives for orphan drug development. This legislation was established to encourage the development of drugs for rare diseases and conditions, which often lack sufficient financial incentives for pharmaceutical companies to invest in them. By providing tax credits for research and development costs, as well as other financial incentives, the Act aims to foster innovation in treating these less common but impactful health issues. This encourages pharmaceutical companies to allocate resources towards developing new therapies that might otherwise be neglected due to limited market potential. The tax incentives effectively lower the financial barriers associated with orphan drug development, promoting a more supportive environment for tackling rare diseases.